TGF-β was found to have increased levels in serum and lung tissue in patients with iPAH compared to controls, which proposes a clue regarding the involvement of TGF-β in the PAH process [77]. The gene discussed is TGFB1; the disease is idiopathic pulmonary arterial hypertension.